Roivant Sciences (ROIV) Gains from Investment Securities (2020 - 2025)

Roivant Sciences' Gains from Investment Securities history spans 6 years, with the latest figure at $17.1 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $17.1 million; the TTM value through Sep 2025 reached -$22.6 million, down 1361374.8%, while the annual FY2025 figure was $139.4 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $17.1 million in Q4 2025 per ROIV's latest filing, up from -$17.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $444.6 million in Q3 2021 to a low of -$17.1 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $62.8 million, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: soared 1438.85% in 2023, then plummeted 1026077.15% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.2 million in 2021, then soared by 732.61% to $9.7 million in 2022, then crashed by 105.29% to -$511000.0 in 2023, then skyrocketed by 100.33% to $1663.0 in 2024, then skyrocketed by 1025877.15% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Gains from Investment Securities are $17.1 million (Q4 2025), -$17.1 million (Q3 2025), and $139.4 million (Q1 2025).